https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1115422/full
Frontiers | Case report: Apatinib combined with neoadjuvant therapy for primary squamous cell...
Primary squamous cell carcinoma of the breast is a rare subtype of carcinoma of chemosis for which there is no effective chemotherapy regimen. Breast squamou...
case report
https://www.spandidos-publications.com/10.3892/ol.2021.12813
Apatinib plus ifosfamide and etoposide for relapsed or refractory osteosarcoma: A retrospective...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.673378/full
Frontiers | Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for...
AbstractObjective: To compare the efficacy and safety of transarterial chemoembolization (TACE) combining with sorafenib or with apatinib for hepatocellular ...
frontierssorafenibversusapatinibcombined
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.943916/full
Frontiers | Response to apatinib and camrelizumab combined treatment in a radioiodine refractory...
Background: Patients with radioactive iodine refractory progressive (RAIR) differentiated thyroid cancer (DTC) often developed resistance after first-line th...